Creatine for Hyrox: dose and timing — Interval

Creatine for Hyrox: dose, timing and what it actually does

Creatine is the most studied supplement in sport and still the one most Hyrox athletes skip. The assumption is that it belongs to powerlifters. But creatine for Hyrox earns its place across the eight stations, where the sled push, the burpee broad jumps and the wall balls all draw on the phosphocreatine system. That system runs dry in about 10 seconds unless it's topped up.

Here's what the research supports, what it doesn't, and how to take it without dragging water weight into a race.

What creatine actually does

Your muscles store creatine as phosphocreatine. During short, maximal efforts, phosphocreatine hands a phosphate to ADP and rebuilds ATP fast. More stored phosphocreatine means you rebuild ATP quicker between efforts and hold power for longer before you fall back on glycolysis.

Supplementing raises muscle creatine stores by roughly 20 to 40 percent depending on where you start (Hultman et al., 1996). Vegetarians and anyone eating little red meat usually see the biggest jump, because their baseline is lower to begin with.

The ISSN position stand on creatine calls it the most effective nutritional supplement available for increasing high-intensity exercise capacity and lean mass during training. That's a firm claim from a body that hedges most things.

What it won't do is make you faster over the 8km of running. The running in Hyrox is aerobic and creatine works on the anaerobic side. If your run splits are the problem, that's a Zone 2 conversation, not a supplement one.

Where it shows up in a Hyrox race

Think about which stations actually leave you doubled over.

The sled push and sled pull are repeated near-maximal efforts with short recoveries between them. Burpee broad jumps are 80m of stop-start power production. Wall balls are 100 reps of the same movement under accumulating fatigue. All three lean hard on phosphocreatine, and all three are where minutes get lost.

Creatine also does quiet work between sessions. Higher muscle stores support training volume and repeat-effort quality, which is where most of the adaptation comes from. Over a 12 week block, small gains in session quality compound into something you can see on a race clock.

There's a secondary effect worth knowing. Creatine supports glycogen storage alongside carbohydrate, which matters if you're carb loading before a race.

Dose and loading

Two protocols, both well supported.

Loading. Roughly 0.3g per kg of bodyweight per day, split into 4 doses, for 5 to 7 days. For most athletes that lands around 20g a day. Then drop to maintenance. Stores saturate in about a week.

Slow load. 3 to 5g a day from the start, or roughly 0.03g per kg. You reach the same saturation in about 28 days, with less GI upset and a gentler water shift.

If you're 8 weeks out from a race, take the slow route. If you're at the start of a training block and want the training benefit sooner, load.

Both end up in the same place. The only difference is how fast you get there and how much your stomach notices.

Timing, and the water weight question

Timing is the part athletes overthink. Daily consistency drives saturation, and that's the whole mechanism. Post-training has slightly better evidence than pre-training in the literature, but the difference is small next to simply taking it every day for a month.

Water retention is the real race-week concern. Creatine pulls water into muscle cells, and that intracellular hydration is part of how it works. Expect 1 to 2kg in the first week of a loading protocol. It sits inside the muscle rather than under the skin, so it doesn't behave like the bloat athletes picture. But if you'd rather not carry it into a race, saturate 6 to 8 weeks out on a low daily dose and skip loading entirely.

Don't stop taking it before a race. Muscle stores wash out over roughly 4 weeks, so a creatine taper achieves nothing except giving back the benefit you spent a month building.

What to buy, and what to ignore

Creatine monohydrate. Unflavoured. That's the answer.

Almost the entire research base is built on monohydrate. Hydrochloride, buffered forms, magnesium chelate and creatine blends all charge more and none of them have beaten monohydrate in head-to-head trials. Micronised monohydrate is the same molecule ground finer, which helps it mix. That's the only upgrade worth paying for.

Check the label states the form and the dose per serving. A product that says "creatine matrix" without printing grams is telling you something.

Interval's Creatine Monohydrate is 300g of unflavoured monohydrate at £12.99, which runs to roughly 60 to 100 servings depending on your daily dose. Stir it into water, coffee or whatever you're already drinking. Consistency matters more than the vehicle.

Who should be careful

Creatine is well tolerated in healthy adults across trials running up to five years. The kidney damage claim has been examined repeatedly in people with normal renal function and hasn't held up.

If you have existing kidney disease, speak to your doctor before starting. If a loading dose gives you GI discomfort, split it into smaller portions with food, or drop to the slow load and accept the longer runway.

Creatine is on the informed-sport tested list with most reputable manufacturers. If you compete in a tested category, buy from a brand that batch tests.

The honest summary

Creatine helps the stations, not the running. It's about 20p a day, it's the best evidenced supplement in the category, and it takes a month of consistency before it does anything.

Start it inside a training block rather than race week. Take 3 to 5g daily. Buy monohydrate. Then keep taking it, because the athletes who get results from creatine are the ones who take it without thinking about it.


Sources

  • Kreider RB et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18.
  • Hultman E et al. Muscle creatine loading in men. J Appl Physiol. 1996;81(1):232-237.
Back to blog